Health Care [ 5/12 ] | Health Care Equipment & Supplies [ 34/75 ]
NASDAQ | Common Stock
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein in the United States.
Its lead product is NELL-1/DBM medical device, an osteopromotive recombinant protein, which provides target specific control over bone regeneration.
The company also develops NB1, a NELL-1/DBM fusion device for use in lumbar spinal fusion, as well as spine implants, non-union trauma cases, and osteoporosis applications.
It serves spine surgeons and patients with a skeletal bone defect or bone-related condition in their spine.
The company has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion by local administration, osteoporosis, and trauma applications.
Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Dec 31, 25 | -0.63 Increased by +78.13% | -0.34 Decreased by -85.29% |
| Nov 14, 25 | -0.37 Increased by +97.40% | -7.92 Increased by +95.33% |
| Aug 14, 25 | -1.33 Decreased by -98.51% | -0.58 Decreased by -129.31% |
| May 12, 25 | -0.32 Increased by +75.61% | -7.68 Increased by +95.84% |
| Feb 26, 25 | -2.88 Decreased by -16.60% | -3.90 Increased by +26.15% |
| Nov 14, 24 | -14.22 Decreased by -2.23 K% | -3.60 Decreased by -295.00% |
| Aug 9, 24 | -0.67 Decreased by -39.58% | -1.39 Increased by +51.80% |
| May 14, 24 | -1.31 Increased by +81.01% | -7.60 Increased by +82.76% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Dec 31, 25 | 0.00 Decreased by N/A% | -684.64 K Increased by +55.01% | Decreased by N/A% Decreased by N/A% |
| Sep 30, 25 | 0.00 Decreased by N/A% | -666.74 K Increased by +29.15% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 25 | 0.00 Decreased by N/A% | -740.52 K Increased by +5.51% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 25 | 0.00 Decreased by N/A% | -1.02 M Decreased by -17.45% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 24 | 0.00 Decreased by N/A% | -1.52 M Increased by +1.82% | Decreased by N/A% Decreased by N/A% |
| Sep 30, 24 | 0.00 Decreased by N/A% | -941.00 K Increased by +50.99% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 24 | 0.00 Decreased by N/A% | -783.73 K Increased by +55.70% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 24 | 0.00 Decreased by N/A% | -865.97 K Increased by +76.66% | Decreased by N/A% Decreased by N/A% |